Please ensure Javascript is enabled for purposes of website accessibility Venture Fund - Janus Henderson Investors
For Financial Professionals in the US

Venture Fund Holdings

Full Portfolio Holdings

(As of 05/31/2024)

% OF INVESTMENTS
Stride Inc 2.04
SS&C Technologies Holdings Inc 1.89
Descartes Systems Group Inc 1.81
Core & Main Inc 1.76
Blackbaud Inc 1.67
LPL Financial Holdings Inc 1.64
Broadridge Financial Solutions Inc 1.63
SPX Technologies Inc 1.63
Globus Medical Inc 1.62
CSW Industrials Inc 1.61
Rentokil Initial PLC (ADR) 1.59
Sensient Technologies Corp 1.58
Constellium SE 1.53
Glaukos Corp 1.47
OSI Systems Inc 1.44
Vaxcyte Inc 1.41
Nice Ltd (ADR) 1.41
ON Semiconductor Corp 1.36
Euronet Worldwide Inc 1.36
Napco Security Technologies Inc 1.26
Valvoline Inc 1.24
Janus International Group Inc 1.24
Tyler Technologies Inc 1.17
Casey's General Stores Inc 1.16
WEX Inc 1.16
EnerSys 1.14
ATS Corp 1.13
Shift4 Payments Inc 1.12
Alight Inc 1.10
Zurn Elkay Water Solutions Corp 1.10
Lantheus Holdings Inc 1.09
ITT Inc 1.06
BellRing Brands Inc 1.02
Williams-Sonoma Inc 1.02
Innospec Inc 1.00
Gates Industrial Corp PLC 0.99
MACOM Technology Solutions Holdings Inc 0.98
Paylocity Holding Corp 0.98
CRA International Inc 0.97
Madrigal Pharmaceuticals Inc 0.96
Ziff Davis Inc 0.95
Bancorp Inc 0.94
Atlanta Braves Holdings Inc 0.93
Alamo Group Inc 0.91
WNS Holdings Ltd 0.90
Magnolia Oil & Gas Corp 0.89
ICON PLC 0.88
Repay Holdings Corp 0.86
Altair Engineering Inc 0.85
Vertex Inc 0.85
ICU Medical Inc 0.79
Ligand Pharmaceuticals Inc 0.79
Monarch Casino & Resort Inc 0.79
RLI Corp 0.77
HealthEquity Inc 0.77
STERIS PLC 0.76
Clarivate PLC 0.75
AvidXchange Holdings Inc 0.75
Gerresheimer AG 0.74
Enpro Inc 0.74
Envestnet Inc 0.72
CACI International Inc 0.69
Loar Holdings Inc 0.68
Ascendis Pharma A/S (ADR) 0.68
Bio-Techne Corp 0.68
Insmed Inc 0.67
Montrose Environmental Group Inc 0.67
Weatherford International PLC 0.65
Camtek Ltd/Israel 0.63
Aramark 0.63
Perimeter Solutions SA 0.62
Avadel Pharmaceuticals PLC 0.60
NeoGenomics Inc 0.58
PDF Solutions Inc 0.58
Walker & Dunlop Inc 0.56
Novanta Inc 0.56
REVOLUTION Medicines Inc 0.54
Biohaven Ltd 0.53
Baldwin Insurance Group Inc 0.53
U-Haul Holding Co 0.52
Ideaya Biosciences Inc 0.52
Doximity Inc 0.52
Lovesac Co 0.50
Halozyme Therapeutics Inc 0.50
Payfare Inc 0.49
FirstService Corp 0.49
Innodata Inc 0.48
MSA Safety Inc 0.48
CECO Environmental Corp 0.48
Tandem Diabetes Care Inc 0.46
Bel Fuse Inc 0.46
Oddity Tech Ltd 0.46
Enfusion Inc 0.46
Assetmark Financial Holdings Inc 0.44
Nordson Corp 0.44
Vivid Seats Inc 0.44
Cognex Corp 0.44
Brady Corp 0.41
Asure Software Inc 0.40
PTC Therapeutics Inc 0.38
Mirum Pharmaceuticals Inc 0.37
Computer Modelling Group Ltd 0.37
Neogen Corp 0.36
California Resources Corp 0.36
Consensus Cloud Solutions Inc 0.36
Thor Industries Inc 0.36
Bridgebio Pharma Inc 0.36
Sarepta Therapeutics Inc 0.34
Kornit Digital Ltd 0.32
Alphatec Holdings Inc 0.30
OmniAb Inc 0.30
Xometry Inc 0.30
Amicus Therapeutics Inc 0.30
Neurocrine Biosciences Inc 0.29
Soleno Therapeutics Inc 0.29
Paragon 28 Inc 0.28
Sotera Health Co 0.27
Apartment List Inc 0.26
Crinetics Pharmaceuticals Inc 0.26
Manchester United Plc 0.25
Arcellx Inc 0.25
AST SpaceMobile Inc 0.24
UL Solutions Inc 0.19
Loadsmart Inc 0.16
89bio Inc 0.16
Claris Ventures SGR SPA 0.16
Rocket Pharmaceuticals Inc 0.15
Ibotta Inc 0.14
Structure Therapeutics Inc (ADR) 0.11
Edgewise Therapeutics Inc 0.10
CryoPort Inc 0.10
QuantumScape Corp 0.09
IntelyCare Inc 0.07
Loadsmart Inc 0.06
OmniAb Operations Inc 0.01
OmniAb Operations Inc 0.01
Perimeter Solutions SA 0.00
Cash & Equivalents 0.18
Janus Henderson publishes this listing of securities held as of the most recently available disclosure period, which varies depending on the portfolio. Any portion of holdings may be excluded from publication when deemed in the best interest of the portfolio. Securities are reported at market value.
The portfolio data and its presentation here is based on the investment book of record and may differ from the accounting book of record and complete schedules of investments in regulatory filings due to differing accounting and reporting standards.